In accordance with Bijié Wǎng, CV5 Capital has partnered with Enzyme to utilize Enzyme Onyx as the foundational technology for issuing and managing tokenized funds, targeting professional and institutional investors. The collaboration combines CV5's regulated Cayman Islands infrastructure with Enzyme's decentralized technology to tokenize hedge funds, digital asset portfolios, and treasury products. These funds will operate under CV5 Digital SPC, complying with the Cayman Islands Monetary Authority (CIMA), and will offer real-time asset visibility and automated net asset value updates. Initial strategies include market-neutral digital asset funds, Bitcoin treasury tools, and tokenized credit opportunities.
CV5 Capital Partners with Enzyme to Launch Institutional Tokenized Fund Solutions
币界网Share
Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.